Aug 9, 2021 | FDA, Featured, ICER, Podcast
On this episode of the podcast, Bob and Kate, filling in for Terry, discuss the attack on Food and Drug Administration accelerated approvals. They point to the recent criticism of the breakthrough Alzheimer’s drug Aduhelm as Exhibit A. Bob explains how...
Read more
Aug 6, 2021 | ICER, Press Releases
FOR IMMEDIATE RELEASE August 5, 2021 WASHINGTON — Patients Rising Executive Director Terry Wilcox today released the following statement regarding today’s report by the Institute for Clinical and Economic Review (ICER); the organization determined the FDA-approved...
Read more
Aug 22, 2020 | Featured, ICER, Podcast, QALY
On this week’s episode of the podcast, Terry and Bob discuss how a Boston nonprofit called the Institute for Clinical and Economic Review (ICER) threatens healthcare for millions of Americans with chronic diseases. Terry and Bob discussed the pernicious...
Read more
Jan 24, 2020 | ICER, Issues, News
Over the next decade, patients living with chronic conditions and rare diseases can expect groundbreaking new treatments, one-time cures and personalized therapies, a new report by the leading experts in the life sciences predicts. “Cures will become the norm, not the...
Read more
